Apogee Therapeutics (APGE) Current Leases (2023 - 2026)
Apogee Therapeutics (APGE) posted quarterly Current Leases of $3.1 million for Q1 2026, down 22.5% year-over-year from $4.0 million in Q1 2025, and down 11.53% quarter-over-quarter from $3.5 million in Q4 2025.
Apogee Therapeutics (APGE) Current Leases (2023 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Current Leases for 4 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 22.5% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 22.5% YoY), while the FY2025 annual figure was $3.5 million, up 8.35% from the prior year.
- Current Leases fell to $3.1 million in Q1 2026 per APGE's latest filing, from $3.5 million in the prior quarter.
- Across five years, Current Leases topped out at $4.1 million in Q3 2025 and bottomed at $1.1 million in Q4 2023.
- Historically, Current Leases has averaged $2.9 million across 4 years, with a median of $3.2 million in 2024.
- Annual changes were most pronounced in 2025 — Current Leases jumped 250.57% — and 2026, when it slipped 22.5%.
- Apogee Therapeutics' Current Leases stood at $1.1 million in 2023, then jumped by 193.73% to $3.2 million in 2024, then grew by 8.35% to $3.5 million in 2025, then declined by 11.53% to $3.1 million in 2026.
- Business Quant data shows APGE's Current Leases at $3.1 million in Q1 2026, $3.5 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.40 Mn |
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.03 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.10 Mn |